Under the leadership of Dr. Shi Yuanyuan, Fosun Kate team leaders visited the smart exhibition hall, GMP level production workshop and R & D laboratory of Shenzhen Cell Valley, and deeply understood the enterprise development, technical service advantages and standardized industrial chain layout.

At the symposium, the two sides shared and exchanged information on the recent development of the industry, the research and development and production implementation of the two companies, and reached a high degree of consensus on the concept of "the development and production pipeline based on retroviral vectors is the trend of cell therapy". Shi Yuan said that Shenzhen Cell Valley, as the only CRO/CDMO one-stop outsourcing service provider that masters industrial retrovirus vector technology (PackRV-SS and other systems) in China, can provide customers with the whole process services from carrier construction, virus vector preparation, cell product preparation, IIT/IND/NDA auxiliary declaration, etc., to rush the market for customers. Shorten time to market. It has formed a multi-property industry linkage, and escorts customers with mature emerging technologies and a full range of services.

Dr. Shen Hao highly praised Shenzhen Cell Valley's senior technical heritage and platform layout thinking, and said that he would work closely with Shenzhen Cell Valley in the IND declaration of the new pipeline, and jointly improve the competitiveness of the upstream and downstream industry chain based on retroviral, and help the validation, transformation, promotion and application of scientific research achievements in the field of cell therapy. Build an ecological chain of leading cell therapy enterprises in Shenzhen.

This exchange visit has further promoted the comprehensive and in-depth cooperation between the two sides, and the two sides have discussed cooperation, sought common development, created a better future, and built hope for thousands of cancer patients.